A novel riboflavin formulation for CXL therapy

CXL therapy may slow or stop the keratoconus from getting worse. This procedure involves puts the application of riboflavin (vitamin B2) to the eye and then activated by UV light for about 30 minutes to strengthen the cornea (by crosslinking cornea’s collagen fibers and surrounding proteins).

Conventional CXL proceduremay require the removal of the thin outer layer of the cornea (epithelium) to allow the riboflavin to more easily penetrate the corneal tissue. In order to solve risks or complications, the purpose of “MedRx’s novel riboflavin formulation” is to improve the diffusion of riboflavin through the epithelium, enough to avoid epithelium debridement in the CXL procedure.